Provided by Tiger Fintech (Singapore) Pte. Ltd.

RAPT Therapeutics, Inc.

0.8744
+0.00981.13%
Volume:741.96K
Turnover:643.01K
Market Cap:115.43M
PE:-0.27
High:0.8886
Open:0.8600
Low:0.8106
Close:0.8646
Loading ...

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting Anti-Ige Antibody

THOMSON REUTERS
·
23 Dec 2024

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody

GlobeNewswire
·
23 Dec 2024

RAPT Therapeutics: Hold Rating Amid Strategic Uncertainties and Financial Resilience

TIPRANKS
·
25 Nov 2024

RAPT Therapeutics Reprices Underwater Employee Stock Options

TIPRANKS
·
16 Nov 2024

RAPT Therapeutics Inc : Stifel Cuts Target Price to $2 From $7

THOMSON REUTERS
·
13 Nov 2024

Stifel Nicolaus Downgrades RAPT Therapeutics to Hold From Buy, Cuts Price Target to $2 From $7

MT Newswires Live
·
13 Nov 2024

RAPT Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

RAPT Therapeutics Q3 EPS $(0.47) Beats $(0.54) Estimate

Benzinga
·
12 Nov 2024

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire
·
12 Nov 2024

RAPT Therapeutics Inc : Leerink Partners Cuts Target Price to $2 From $10

THOMSON REUTERS
·
12 Nov 2024

RAPT Therapeutics Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2 From $8

THOMSON REUTERS
·
12 Nov 2024

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
12 Nov 2024

RAPT Shares Fall to All-Time Low After Zelnecirnon Programs Terminated

Dow Jones
·
12 Nov 2024

Piper Sandler Downgrades RAPT Therapeutics to Neutral From Overweight; Shares Tumble

MT Newswires Live
·
12 Nov 2024

BUZZ-Rapt plummets on discontinuation of experimental drug for eczema and asthma

Reuters
·
12 Nov 2024

Top Midday Decliners

MT Newswires Live
·
12 Nov 2024

Rapt Therapeutics Cut to Underweight From Neutral by JP Morgan

Dow Jones
·
12 Nov 2024

JPMorgan Downgrades RAPT Therapeutics to Underweight From Neutral; Shares Plunge

MT Newswires Live
·
12 Nov 2024

Rapt Therapeutics model under review at Stifel after zelnecirnon discontinued

TIPRANKS
·
11 Nov 2024

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results

Benzinga
·
11 Nov 2024